FDA Inspection
Baptist Health IRB #1Baptist Health IRB #1 – FDA Inspection, Sep 28, 2023
Record Details
This FDA Inspection record concerns Baptist Health IRB #1, with an inspection on September 28, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · c1090dfa-dd72-4d0f-81a9-ae4c6c589f01
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1219429
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 56.109(e)IRB approvals/disapprovals - general
- 21 CFR 56.113Reporting
- 21 CFR 56.109(e)IRB approvals/disapprovals - general
- 21 CFR 56.113Reporting
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baptist Health IRB #1
2| Date | Classification | Office | Project area |
|---|---|---|---|
| February 22, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 8, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Baptist Health IRB #1
- FDA Inspection 1041815 - 2018-02-22
- FDA Inspection 768288 - 2012-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.